In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccineKar Muthumani, David B. Weiner, Bryan D. Griffin et al.|npj Vaccines|2016Cited by 136
Zika Vaccine Development—Current Progress and Challenges for the FutureJoel N. Maslow|Tropical Medicine and Infectious Disease|2019Cited by 21